Beta Bionics, Inc.

Beta Bionics, Inc. belongs to the small but important group of diabetes technology companies, and that means people managing insulin needs are the ones who pay attention to it. By our assessment, the standout feature is its focus on automated insulin delivery, especially the iLet system, which is built to reduce the amount of manual calculation patients have to do. The downside is that this is still a device with real setup, training, and hardware limits, so it is not a casual wellness gadget. In practice, the appeal is in less finger-counting and more system-driven dosing, which changes the daily feel of diabetes management. It sits alongside other pump and closed-loop manufacturers, but with a distinctive emphasis on simplifying the user’s decisions. The rating is strong because it tackles a hard medical job with a very clear purpose.